I raised with the Prime Minister, the importance of early diagnosis and treatment for conditions such as 22q11 Syndrome.
This condition, which is second most common chromosomal disorder after Down’s Syndrome, is the most common genetic disorder you’ve never heard of.
We await the result of the National Screening Committee who is currently looking at the validity of adding this condition to the newborn blood-spot test.
UPDATE (30 Mar 2019):
On 29 Mar 2019, we were informed that 22q11DS has indeed passed the first phase of approval for screening by the NSC. Further, more detailed assessment is ongoing.
